Caricamento...
Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations
BACKGROUND: IPX066 is an extended-release (ER) oral formulation of carbidopa-levodopa (CD-LD). Following an initial peak at about one hour, plasma LD concentrations are maintained for about 4-5 hours. OBJECTIVE: To present dosing factors that may affect the successful conversion to ER CD-LD from oth...
Salvato in:
| Pubblicato in: | Parkinsons Dis |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217748/ https://ncbi.nlm.nih.gov/pubmed/30425824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9763057 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|